Canada to Consider Allowing Psychedelic-Assisted Therapy under Special Access Program Amendment Post published:December 12, 2020 Post category:Analysis/News
Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme Post published:December 11, 2020 Post category:Press Release
MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m) Post published:December 11, 2020 Post category:Press Release
Psychedelic Bulletin: Canadian Healthcare Professionals Allowed Psilocybin; UK Approves DMT Trial Post published:December 11, 2020 Post category:Psychedelic Bulletin
Andrew Chadeayne, Founder and CEO of CaaMTech Post published:December 10, 2020 Post category:Interview
Field Trip Health Ltd. Announces Increase to Bought Deal Financing to $17.4 Million Post published:December 10, 2020 Post category:Press Release
Field Trip Health Ltd. Announces $15 Million Bought Deal Offering of Units Post published:December 10, 2020 Post category:Press Release
Pure Extracts Preparing Application for Dealers Licence Post published:December 10, 2020 Post category:Press Release
Tryp Therapeutics Files Final Prospectus and Announces Initial Public Offering Post published:December 10, 2020 Post category:Press Release